» Articles » PMID: 37093319

Impact of Smoking on Urologic Cancers: a Snapshot of Current Evidence

Overview
Journal World J Urol
Specialty Urology
Date 2023 Apr 24
PMID 37093319
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: The purpose of this paper is to present evidence regarding the associations between smoking and the following urologic cancers: prostate, bladder, renal, and upper tract urothelial cancer (UTUC).

Methods: This is a narrative review. PubMed was queried for evidence-based analyses and trials regarding the associations between smoking and prostate, bladder, renal, and UTUC tumors from inception to September 1, 2022. Emphasis was placed on articles referenced in national guidelines and protocols.

Results: Prostate-multiple studies associate smoking with higher Gleason score, higher tumor stage, and extracapsular invasion. Though smoking has not yet been linked to tumorigenesis, there is evidence that it plays a role in biochemical recurrence and cancer-specific mortality. Bladder-smoking is strongly associated with bladder cancer, likely due to DNA damage from the release of carcinogenic compounds. Additionally, smoking has been linked to increased cancer-specific mortality and higher risk of tumor recurrence. Renal-smoking tobacco has been associated with tumorigenesis, higher tumor grade and stage, poorer mortality rates, and a greater risk of tumor recurrence. UTUC-tumorigenesis has been associated with smoking tobacco. Additionally, more advanced disease, higher stage, lymph node metastases, poorer survival outcomes, and tumor recurrence have been linked to smoking.

Conclusion: Smoking has been shown to significantly affect most urologic cancers and has been associated with more aggressive disease, poorer outcomes, and tumor recurrence. The role of smoking cessation is still unclear, but appears to provide some protective effect. Urologists have an opportunity to engage in primary prevention by encouraging cessation practices.

Citing Articles

Perioperative Intensive Smoking Cessation Intervention Among Smokers Who Underwent Transurethral Resection of Bladder Tumor (TURBT) in Two Different Settings: A Randomized Controlled Trial.

Lydom L, Lauridsen S, Liljendahl M, Schmedes A, Joensen U, Tonnesen H Cancers (Basel). 2025; 17(4).

PMID: 40002306 PMC: 11853449. DOI: 10.3390/cancers17040713.


The Potential for Lifestyle Intervention Among Patients Undergoing Transurethral Resection of Bladder Tumour Based on Patient Needs Including Smoking and Other Risky Lifestyle Factors: A Cross-Sectional Study.

Lydom L, Lauridsen S, Joensen U, Tonnesen H Int J Environ Res Public Health. 2025; 21(12.

PMID: 39767473 PMC: 11675626. DOI: 10.3390/ijerph21121633.


Clinical and Pathological Characteristics of Bladder Cancer in Patients Aged 18-45 Undergoing Transurethral Resection of Bladder Tumor.

Croitor A, Dema V, Latcu S, Bardan R, Novacescu D, Barbos V Biomedicines. 2024; 12(11).

PMID: 39595014 PMC: 11591727. DOI: 10.3390/biomedicines12112449.


Association between smoking and prostate cancer survivors' long-term quality of life and function: an analysis of the CEASAR (Comparative Effectiveness Analysis of Surgery and Radiation) study.

Nguyen D, Barocas D, Zhao Z, Huang L, Koyama T, Al Hussein Ai Awamlh B J Cancer Surviv. 2024; .

PMID: 39400687 DOI: 10.1007/s11764-024-01692-2.


Same Organ, Two Cancers: Complete Analysis of Renal Cell Carcinomas and Upper Tract Urothelial Carcinomas.

Vamesu S, Ursica O, Milea S, Deacu M, Aschie M, Mitroi A Medicina (Kaunas). 2024; 60(7).

PMID: 39064555 PMC: 11279004. DOI: 10.3390/medicina60071126.


References
1.
Mori K, Mostafaei H, Abufaraj M, Yang L, Egawa S, Shariat S . Smoking and bladder cancer: review of the recent literature. Curr Opin Urol. 2020; 30(5):720-725. DOI: 10.1097/MOU.0000000000000804. View

2.
Miyazaki J, Nishiyama H . Epidemiology of urothelial carcinoma. Int J Urol. 2017; 24(10):730-734. DOI: 10.1111/iju.13376. View

3.
Capitanio U, Bensalah K, Bex A, Boorjian S, Bray F, Coleman J . Epidemiology of Renal Cell Carcinoma. Eur Urol. 2018; 75(1):74-84. PMC: 8397918. DOI: 10.1016/j.eururo.2018.08.036. View

4.
Hagiwara M, Kikuchi E, Tanaka N, Matsumoto K, Ide H, Miyajima A . Impact of smoking status on bladder tumor recurrence after radical nephroureterectomy for upper tract urothelial carcinoma. J Urol. 2013; 189(6):2062-8. DOI: 10.1016/j.juro.2013.01.024. View

5.
Li H, Azhati B, Rexiati M, Wang W, Li X, Liu Q . Impact of smoking status and cumulative smoking exposure on tumor recurrence of non-muscle-invasive bladder cancer. Int Urol Nephrol. 2016; 49(1):69-76. DOI: 10.1007/s11255-016-1441-6. View